HomeCompareMDDVF vs ORCC

MDDVF vs ORCC: Dividend Comparison 2026

MDDVF yields 539.59% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDDVF wins by $343.2K in total portfolio value
10 years
MDDVF
MDDVF
● Live price
539.59%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$364.6K
Annual income
$974.10
Full MDDVF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — MDDVF vs ORCC

📍 MDDVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDDVFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDDVF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDDVF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDDVF
Annual income on $10K today (after 15% tax)
$45,865.37/yr
After 10yr DRIP, annual income (after tax)
$827.99/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, MDDVF beats the other by $827.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDDVF + ORCC for your $10,000?

MDDVF: 50%ORCC: 50%
100% ORCC50/50100% MDDVF
Portfolio after 10yr
$193.0K
Annual income
$487.57/yr
Blended yield
0.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

MDDVF
No analyst data
Altman Z
3.5
Piotroski
4/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDDVF buys
0
ORCC buys
0
No recent congressional trades found for MDDVF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDDVFORCC
Forward yield539.59%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$364.6K$21.4K
Annual income after 10y$974.10$1.04
Total dividends collected$219.9K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: MDDVF vs ORCC ($10,000, DRIP)

YearMDDVF PortfolioMDDVF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$37,680$26,979.63$11,190$489.61+$26.5KMDDVF
2$87,821$47,503.86$12,229$256.01+$75.6KMDDVF
3$145,706$51,737.70$13,216$130.74+$132.5KMDDVF
4$196,018$40,111.86$14,207$66.02+$181.8KMDDVF
5$234,955$25,215.98$15,234$33.17+$219.7KMDDVF
6$265,525$14,123.79$16,317$16.62+$249.2KMDDVF
7$291,571$7,458.64$17,468$8.32+$274.1KMDDVF
8$315,808$3,827.22$18,695$4.16+$297.1KMDDVF
9$339,852$1,937.09$20,006$2.08+$319.8KMDDVF
10$364,615$974.10$21,407$1.04+$343.2KMDDVF

MDDVF vs ORCC: Complete Analysis 2026

MDDVFStock

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.

Full MDDVF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this MDDVF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDDVF vs SCHDMDDVF vs JEPIMDDVF vs OMDDVF vs KOMDDVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.